Viewing Study NCT04217395


Ignite Creation Date: 2025-12-24 @ 1:20 PM
Ignite Modification Date: 2026-02-20 @ 1:32 PM
Study NCT ID: NCT04217395
Status: UNKNOWN
Last Update Posted: 2023-09-01
First Post: 2019-12-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Quality of Life and Autonomy in Health of Overweight or Obese People Receiving Reinforced Support
Sponsor: Hospices Civils de Lyon
Organization:

Study Overview

Official Title: Implementation and Effectiveness of a Reinforced Support Program for People Who Are Overweight or Obese to Improve Their Autonomy in Health and Quality of Life
Status: UNKNOWN
Status Verified Date: 2023-08
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Eval-Xailes
Brief Summary: This mixed-methods prospective cohort study aims to evaluate a recently implemented reinforced support program named "X-ailes program".

The X-Ailes program is a face-to-face or telephone-based support program by health-system navigators/case-managers, funded by the French Ministry of Health (program for empowerment of care users). X-Ales is developed by an patients and public association to support overweight or obese care users facing difficulty to access to care or resources regarding the management of their health situation.

The subjects of the present study are the overweight or obese care-users followed-up by the X-Ailes program.

The aim of the study Eval-X-ailes is to assess the effect of the support program X-Ailes on quality of life, autonomy and literacy of overweight or obese care users at 12 months.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: